SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the safety and efficacy of corticosteroid discontinuation
versus cyclosporine micro emulsion discontinuation in recipients receiving reduced exposure
cyclosporine micro emulsion and corticosteroids plus enteric-coated mycophenolate sodium
(EC-MPS) initially, changed to everolimus at 2 weeks post-transplant. These two groups will
be compared to a third control group, who will receive treatment consisting of cyclosporine
micro emulsion, enteric-coated mycophenolate sodium (EC-MPS) and steroids.